Hypera S.A., which operates as Hypera Pharma, is a Brazilian pharmaceutical company focused on the domestic market. The company is dedicated to the development, production and sale of a wide portfolio of pharmaceutical products, with a presence in almost every point of sale in Brazil. Its operations cover all pharmaceutical retail segments, with a portfolio of leading brands highlighted. The company also operates in the Institutional Market, which includes public sector sales. The business model is supported by investments in innovation, new product launches in its business units, and the expansion of production capacity. The company invests in the production of strategic inputs and in new plants for products such as oncology and biologics to support its growth. Fonts
The sum of declared dividends issued by a company for every ordinary share outstanding.
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
The average of the dividend yield over the last 60 months.
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
...and much more!